👋
Is this profile yours? Take control to keep your details current, set fees, and respond to reviews.
This page is aggregated from public sources.
Claim this profile →
Trust score 8/100
Accepting new patients
Dr
Dr Miranda Payne
Oncology
English
12,216+
Patients seen
6
Years in practice
10
Publications
1
Languages spoken
About
Dr Miranda Payne is a Consultant in Medical Oncology, specialising exclusively in
the treatment of skin cancers, with particular expertise in the systemic
treatment of melanoma including non-cutaneous melanoma.
Miranda took a first in Physiology from the University
of Oxford before completing her clinical training in 1999. In 2006 Miranda was
awarded a Cancer Research UK Clinical Fellowship, spending four years carrying
our laboratory research in DNA repair at the Weatherall Institute of Molecular
Medicine, leading to a DPhil in Medical Oncology. Specialist training was
completed in Oxford, where she is now the Clinical Lead for Oncology at the
Oxford University Hospitals NHS Foundation Trust.
In her NHS practise, recruitment to international, academic,
industry-sponsored and observational clinical trials is a routine aspect of Miranda's
clinical practice, reflected in her publication record. She has a special
interest in the consequences of immunotherapy and in the management of mucosal
melanoma.
Miranda is the Thames Valley and South Midlands Skin Cancer Research Lead, was an elected member of the National Cancer Research Institute Skin Group, is a co-author of the recently published UK guidelines for the management of both Ano-uro-genital Mucosal Melanoma and Head & Neck Mucosal Melanoma, works with Melanoma Focus (the UK national charity dedicated to research, treatment, education and information for patients, their families and their clinical teams) and has been an editor of
the Oxford Handbook of Oncology for almost twenty years.
the treatment of skin cancers, with particular expertise in the systemic
treatment of melanoma including non-cutaneous melanoma.
Miranda took a first in Physiology from the University
of Oxford before completing her clinical training in 1999. In 2006 Miranda was
awarded a Cancer Research UK Clinical Fellowship, spending four years carrying
our laboratory research in DNA repair at the Weatherall Institute of Molecular
Medicine, leading to a DPhil in Medical Oncology. Specialist training was
completed in Oxford, where she is now the Clinical Lead for Oncology at the
Oxford University Hospitals NHS Foundation Trust.
In her NHS practise, recruitment to international, academic,
industry-sponsored and observational clinical trials is a routine aspect of Miranda's
clinical practice, reflected in her publication record. She has a special
interest in the consequences of immunotherapy and in the management of mucosal
melanoma.
Miranda is the Thames Valley and South Midlands Skin Cancer Research Lead, was an elected member of the National Cancer Research Institute Skin Group, is a co-author of the recently published UK guidelines for the management of both Ano-uro-genital Mucosal Melanoma and Head & Neck Mucosal Melanoma, works with Melanoma Focus (the UK national charity dedicated to research, treatment, education and information for patients, their families and their clinical teams) and has been an editor of
the Oxford Handbook of Oncology for almost twenty years.
“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”
— Dr Miranda Payne
Education & training
-
2010–2016 MD · Medicine and Surgery
-
2016–2020 Residency · Oncology
-
2020–2021 Fellowship · Subspecialty training
Career & appointments
-
2020-09–2021-08 Junior consultant
Licenses & insurance
Medical licenses
GB — Organización Médica Colegial de España (OMC)
Board certifications
European Board of Oncology
Malpractice insurance:
Generali Healthcare · 4,000,000 EUR coverage
· No claims on file
Procedures performed
| Procedure | Code | Lifetime count |
|---|---|---|
| GP consultation | 99213 | 1,045 |
| Annual physical exam | 99395 | 1,403 |
| Vaccination administration | 90471 | 1,123 |
| Minor procedure (skin) | 17110 | 428 |
Services & pricing
| Service | Duration | Modality | Price |
|---|---|---|---|
| New patient consultation (60m) | 60 min | in_clinic|telemed | 180.00 EUR |
| Follow-up consultation (30m) | 30 min | in_clinic|telemed|phone | 90.00 EUR |
| Vaccination administration | 30 min | in_clinic | 630.00 EUR |
| Minor procedure (skin) | 120 min | in_clinic | 720.00 EUR |
Office, team & in practice
Videos
Research & publications
h-index: 13 · i10: 5
-
Outcomes of Oncology in adults — a multi-centre cohort
DOI: 10.1283/euroclin.2025.0 · PMID: 36373064 · cited by 77
-
European registry analysis of Oncology outcomes
DOI: 10.9969/euroclin.2024.1 · PMID: 37046421 · cited by 119
Invited talks
- Practical updates in Oncology European Annual Congress (Oncology) · Vienna · 2024 · invited
- Single-centre experience in Oncology National Society Meeting · · 2023 · oral abstract
Awards & memberships
Awards
- 🏆 Top-rated Oncology — · EuroClinics Patient Choice · 2025 · regional
Society memberships
- WONCA Europe — Family Doctors — Member · since 2021
- national college of family doctors — Member · since 2021
- European Union of Medical Specialists (UEMS) — Member · since 2021
Patient reviews
- Bedside Manner
- 0.05
- Knowledge
- 0.08
- Wait Time
- 3.80
- Staff Friendliness
- 0.02
- Ease Of Appointment
- 4.00
- Value For Money
- 4.10
- Would Recommend Pct
- 4
-
★ 5 verified visit
“Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.”
-
★ 5 verified visit
“Took time to listen and reviewed all my previous results. I would absolutely recommend.”
-
★ 4 verified visit
“Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.”
Articles by this doctor
- Patient education Patient guide to Oncology
- Awareness When should you see a oncology?
For international patients
- Coordinator
- Patient liaison · miranda.jane.payne@euroclinics.example
